Navigation Links
European Interspinous Process Decompression Device Market Will Grow Nominally at 1.2% over the Next Five Years

TORONTO, Sept. 1 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, although interspinous process decompression devices will continue to be used in a narrow set of indications over the next five years in Europe, the market will grow at a much lower rate than previously expected.  With a compound annual growth rate of 1.2%, this is low compared to the nonfusion market as a whole which is growing on average at 10%.

A form of dynamic stabilization – interspinous process decompression device procedures were the most commonly performed nonfusion surgery in Europe in 2009, accounting for nearly 40% of all spinal nonfusion procedures.  Rapid adoption in the past was due in large part to the ease-of-use of the devices, resulting in surgeons implanting them for the treatment of broad indications. Surgeon use of these devices for inappropriate indications, however, resulted in many cases of device failure, which then led to a high volume of revision surgeries. As a result, reimbursement approvals for these devices are becoming stricter and are only granted when used in appropriate indications. Slowing in the number interspinous process decompression device procedures will result in decreased surgeon uptake of popular interspinous process decompression devices, including Medtronic Spinal & Biologic's X-STOP and DIAM, Paradigm Spine's coflex and Zimmer Spine's Wallis.

"Surgeons are losing their initial enthusiasm about the technology, which is attributed to doubts about how effective interspinous process decompression devices are in treating pathological conditions of the spine," says Andrew Lee, Analyst at MRG. "Payors in the UK and Italy are placing pressure on hospitals to reduce the use of interspinous process decompression devices by narrowing the indications for which the devices are reimbursed. Furthermore, poor clinical results in the medical literature will continue to curb the appeal of these devices to many surgeons in the future".

MRG's European Markets for Spinal Implants 2010 report provides critical insight into emerging trends that will fuel product adoption and the growth of the spinal fusion implant market, including traditional cervical and thoracolumbar fixation devices and interbody devices, as well as the spinal nonfusion device market, including interspinous process decompression devices, pedicle screw-based dynamic stabilization systems, cervical and lumbar artificial discs, nuclear disc prostheses, annulus repair devices and facet arthroplasty devices in France, Germany, Italy, Spain and the UK through 2014.

About Millennium Research GroupMillennium Research Group (, a Decision Resources, Inc. company (, is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer behavior tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:



Amy Krohn


Millennium Research Group


416-364-7776 ext. 101



Chris Comfort


Decision Resources Inc.




SOURCE Millennium Research Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. For Treatment of Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia, 41 Percent of Surveyed European Hematologist-Oncologists Say MabTheras Favorable Efficacy Profile is the Most Significant Driver of Their Use of This Agent
2. Mindray Medical to Present at the Goldman Sachs 7th Annual European Medtech and Healthcare Services Conference
3. Sunridge Schedules European Meetings
4. European Patent Office Upholds GlideScope® Video Laryngoscope Patent
5. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
6. Cardiac Dimensions® Announces Presentation of 12-Month Follow-up Data of TITAN™ Trial at European Society of Cardiology Meeting
7. Reportlinker Adds European Markets for Small Joint Reconstructive Devices 2010 (15 Countries)
8. PDL BioPharma Receives Letter from Genentech Relating to European Patents
9. Western European Market for Image-guided and Robot-assisted Surgery
10. European Research Project Aims to Improve the Diagnosis and Therapy of Brain Diseases
11. Health Robotics CytoCare Continues European Expansion With Grifols and Vall dHebron University Hospital
Post Your Comments:
(Date:11/25/2015)... 2015 --> ... Lizenz für das Patent über eine neue Hepatitis-B-Behandlung, welches ... innehaben, an Enyo Pharma vergeben haben. Im ... gerufenen und von Edelris gemeinsam mit seinen Partnern Inserm ... für HBV identifiziert, und es wurden neue Inhaltsstoffe entdeckt, ...
(Date:11/24/2015)... , Nov. 25, 2015 WuXi PharmaTech ... ), a leading open-access R&D capability and technology platform ... with operations in China and ... that at an extraordinary general meeting of shareholders held ... proposal to authorize and approve the previously announced agreement ...
(Date:11/24/2015)... Nov. 24, 2015  Array BioPharma Inc. (Nasdaq: ... Executive Officer, Ron Squarer , will present ... New York.  The public is welcome to participate ... Array BioPharma website.Event:Piper Jaffray Annual Healthcare ConferencePresenter:  , ... 2, 2015Time:1:30 p.m. Eastern Time Webcast: ...
Breaking Medicine Technology:
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... ) has focused on providing comprehensive solutions involving adult stem cell therapies to ... has officially deemed the “Regenestem” name as a Registered Trademark (RTM). , Organizations ...
(Date:11/24/2015)... Clearwater, Florida (PRWEB) , ... November 25, 2015 ... ... care planning and monitoring. Their Care Plan software creates an agreement between ... the patient care plan, including financial, scheduling, monitoring, notification, and projections. Click ...
(Date:11/24/2015)... Mississauga, ON (PRWEB) , ... November 24, 2015 , ... ... Deborah Williams without a referral for dental implants at her Mississauga, ON ... qualified and experienced in the placement of dental implants. , Missing teeth can ...
(Date:11/24/2015)... CA (PRWEB) , ... November 24, 2015 , ... ... sizes, has launched their Black Friday sale a week early, offering 40% off ... to transform the intimate apparel industry through both mobile fit technology and the ...
(Date:11/24/2015)... ... November 24, 2015 , ... DMG Productions announced that they ... airing first quarter 2016 via Discovery Channel. Dates and show times TBA. , Aphria, ... is in the business of producing and supplying medical marijuana pursuant to the Marijuana ...
Breaking Medicine News(10 mins):